Vitamin C and E supplementation does not reduce the risk of superimposed PE in pregnancy
- PMID: 21174586
- DOI: 10.3109/10641955.2010.507840
Vitamin C and E supplementation does not reduce the risk of superimposed PE in pregnancy
Abstract
Background: Oxidative stress could play a role in the development of preeclampsia. There is some evidence to suggest that vitamin C and E supplements can reduce the risk of the disorder. We hypothesized its beneficial role in a group of pregnant women with essential hypertension.
Methods: In this randomized controlled trial, we enrolled 50 pregnant women with essential hypertension. We assigned the women 1000 mg vitamin C and 400 IU natural vitamin E (RRR α tocopherol; n = 25), daily from the second trimester of pregnancy until delivery or no supplementation (n = 25). Our primary endpoint was development of superimposed preeclampsia, and main secondary endpoints were aggravation of hypertension, need for admission, need to increase antihypertensive drugs, and small size for gestational age (<fifth customized birthweight centile).
Results: We analyzed 50 women who completed the study. The incidence of superimposed preeclampsia was similar in vitamin and control groups (8% [n = 2] vs 12% [n = 3], p = 1.000). Vitamin C and E supplementation also did not prevent aggravation of hypertension in group of women who took it (12% [n = 3] vs 32% [n = 8], p = 0.172). Small size for gestational age babies did not differ between groups (4% [n = 2] vs 6% [n = 3], p = 1.000).
Conclusion: Vitamin C and E supplementation does not prevent development of superimposed preeclampsia in women with essential hypertension. Our results did not show any significant benefit of vitamin supplementation. There was some trend in lessening of hypertensive complications of pregnancy. Our results failed to find any correlation between development of superimposed preeclampsia and oxidative stress.
Similar articles
-
Influence of mineral and vitamin supplements on pregnancy outcome.Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):127-32. doi: 10.1016/j.ejogrb.2012.06.020. Epub 2012 Jul 6. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22771225 Review.
-
A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women.Hypertens Pregnancy. 2009 Aug;28(4):417-34. doi: 10.3109/10641950802629667. Hypertens Pregnancy. 2009. PMID: 19843004
-
Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study.Hypertension. 2008 Apr;51(4):1002-9. doi: 10.1161/HYPERTENSIONAHA.107.107565. Epub 2008 Feb 7. Hypertension. 2008. PMID: 18259010 Clinical Trial.
-
Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.Lancet. 2006 Apr 8;367(9517):1145-54. doi: 10.1016/S0140-6736(06)68433-X. Lancet. 2006. PMID: 16616557 Clinical Trial.
-
Vitamin E in preeclampsia.Ann N Y Acad Sci. 2004 Dec;1031:242-8. doi: 10.1196/annals.1331.024. Ann N Y Acad Sci. 2004. PMID: 15753150 Review.
Cited by
-
Dysbiotic lung microbial communities of neonates from allergic mothers confer neonate responsiveness to suboptimal allergen.Front Allergy. 2023 Mar 10;4:1135412. doi: 10.3389/falgy.2023.1135412. eCollection 2023. Front Allergy. 2023. PMID: 36970065 Free PMC article.
-
Oxidative Stress, Antioxidants and Hypertension.Antioxidants (Basel). 2023 Jan 27;12(2):281. doi: 10.3390/antiox12020281. Antioxidants (Basel). 2023. PMID: 36829839 Free PMC article. Review.
-
Micronutrient supplementation interventions in preconception and pregnant women at increased risk of developing pre-eclampsia: a systematic review and meta-analysis.Eur J Clin Nutr. 2023 Jul;77(7):710-730. doi: 10.1038/s41430-022-01232-0. Epub 2022 Nov 9. Eur J Clin Nutr. 2023. PMID: 36352102 Free PMC article. Review.
-
Medications for preventing hypertensive disorders in high-risk pregnant women: a systematic review and network meta-analysis.Syst Rev. 2022 Jul 1;11(1):135. doi: 10.1186/s13643-022-01978-5. Syst Rev. 2022. PMID: 35778751 Free PMC article.
-
Towards Personalized Antioxidant Use in Female Infertility: Need for More Molecular and Clinical Studies.Biomedicines. 2021 Dec 17;9(12):1933. doi: 10.3390/biomedicines9121933. Biomedicines. 2021. PMID: 34944748 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical